{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:19:26Z","timestamp":1788297566525,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd007524.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000}}],"reference-count":104,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007524.pub5","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T14:32:25Z","timestamp":1664202745000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children"],"prefix":"10.1002","volume":"2022","author":[{"given":"Kayleigh M","family":"Kew","sequence":"additional","affiliation":[{"name":"London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Flemyng","sequence":"additional","affiliation":[{"name":"Evidence Production and Methods Directorate; Cochrane; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley S","family":"Quon","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarus","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of British Columbia; Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"10.1002\/14651858.CD007524.pub5-BIB0001|cit1","unstructured":"Treatment of acute exacerbations of asthma in children with a doubling of the usual inhaled corticosteroid (ICS) dose www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=630"},{"issue":"7","key":"10.1002\/14651858.CD007524.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/thx.2003.014936","article-title":"Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations","volume":"59","author":"FitzGerald","year":"2004","journal-title":"Thorax"},{"issue":"2","key":"10.1002\/14651858.CD007524.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1378\/chest.117.2.440","article-title":"Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control","volume":"117","author":"Foresi","year":"2000","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD007524.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/adc.79.1.12","article-title":"Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid","volume":"79","author":"Garrett","year":"1998","journal-title":"Archives of Disease in Childhood"},{"issue":"9405","key":"10.1002\/14651858.CD007524.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(03)15384-6","article-title":"Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial","volume":"363","author":"Harrison","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD007524.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa1710988","article-title":"Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations","volume":"378","author":"Jackson","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0007|cit7","unstructured":"Step-up yellow zone inhaled corticosteroids to prevent exacerbations (STICS) clinicaltrials.gov\/ct2\/show\/NCT02066129"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(10)62145-9","article-title":"Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Martinez","year":"2011","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD007524.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.200904-0616OC","article-title":"Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double blind, placebo controlled, parallel group, clinical trial","volume":"180","author":"Oborne","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"12","key":"10.1002\/14651858.CD007524.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1445-5994.2005.00972.x","article-title":"Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults","volume":"35","author":"Rice-McDonald","year":"2005","journal-title":"Internal Medicine Journal"},{"issue":"3","key":"10.1002\/14651858.CD007524.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.pupt.2007.11.002","article-title":"Randomized comparison of ciclesonide 160 and 640 \u03bcg\/day in severe asthma","volume":"21","author":"Bateman","year":"2008","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"issue":"15","key":"10.1002\/14651858.CD007524.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa042552","article-title":"Daily versus as-needed corticosteroids for mild persistent asthma","volume":"352","author":"Boushey","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD007524.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.rmed.2011.07.017","article-title":"Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy","volume":"105","author":"Brand","year":"2011","journal-title":"Respiratory Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007524.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0735-6757(96)90120-5","article-title":"Early corticosteroid use in acute exacerbations of chronic airflow obstruction","volume":"14","author":"Bullard","year":"1996","journal-title":"American Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0015|cit15","volume-title":"Airway Challenges in Different Clinical Phenotypes and Their Relationship to Markers of Disease and Treatment [PhD thesis]","author":"Clearie","year":"2010"},{"issue":"4","key":"10.1002\/14651858.CD007524.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1081-1206(10)63288-7","article-title":"The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma","volume":"82","author":"Condemi","year":"1999","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"1","key":"10.1002\/14651858.CD007524.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/adc.68.1.85","article-title":"Prevention of viral induced asthma attacks using inhaled budesonide","volume":"68","author":"Connett","year":"1993","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1002\/14651858.CD007524.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00228-003-0571-9","article-title":"Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients","volume":"59","author":"Currie","year":"2003","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD007524.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1081\/JAS-200062966","article-title":"Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation","volume":"42","author":"De Benedictis","year":"2005","journal-title":"Journal of Asthma"},{"issue":"8","key":"10.1002\/14651858.CD007524.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1651-2227.1999.tb00057.x","article-title":"Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma","volume":"88","author":"Singhi","year":"1999","journal-title":"Acta Paediatrica"},{"issue":"3","key":"10.1002\/14651858.CD007524.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.chest.2016.06.024","article-title":"POINT: is escalation of the inhaled corticosteroid dose appropriate for acute loss of asthma control in an attempt to reduce need for oral corticosteroids in children? Yes","volume":"150","author":"Farber","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD007524.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1155\/2000\/587957","article-title":"A randomized, controlled trial of high dose, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation","volume":"7","author":"FitzGerald","year":"2000","journal-title":"Canadian Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD007524.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"P328","DOI":"10.1016\/S2213-2600(18)30118-8","article-title":"Effect of increasing glucocorticoids on asthma exacerbations","volume":"6","author":"Gilbert","year":"2018","journal-title":"Lancet Respiratory Medicine"},{"issue":"8917","key":"10.1002\/14651858.CD007524.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(94)92996-3","article-title":"Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid","volume":"344","author":"Greening","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0025|cit25","unstructured":"A multicentre, double-blind, randomised, four-week, parallel-group comparison of inhaled fluticasone propionate and inhaled beclomethasone dipropionate in patients with severe asthma controlled by high-dose inhaled corticosteroids (FLIP04) www.gsk-clinicalstudyregister.com\/study\/FMS30049#rs"},{"issue":"2","key":"10.1002\/14651858.CD007524.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"AB24","DOI":"10.1016\/j.jaci.2019.12.801","article-title":"Step-up to high dose fluticasone furoate in combination with long-acting bronchodilator in inadequately controlled asthma: the CAPTAIN study","volume":"145","author":"Hanania","year":"2020","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD007524.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1651-2227.1999.tb01267.x","article-title":"Systemic effects of a short course of betamethasone compared with high-dose inhaled budesonide in early childhood asthma","volume":"88","author":"Hedlin","year":"1999","journal-title":"Acta Paediatrica"},{"issue":"9","key":"10.1002\/14651858.CD007524.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0954-6111(99)90100-2","article-title":"The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma","volume":"93","author":"Heinig","year":"1999","journal-title":"Respiratory Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007524.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.rmed.2006.06.005","article-title":"Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma","volume":"101","author":"Karpel","year":"2007","journal-title":"Respiratory Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007524.pub5-BIB0030|cit30","first-page":"23","article-title":"Double-blind study of inhaled salbutamol versus salbutamol plus high-dose flunisolide in exacerbation of bronchial asthma: a pilot study","volume":"11","author":"La Rosa","year":"1997","journal-title":"Pediatric Asthma, Allergy and Immunology"},{"issue":"4","key":"10.1002\/14651858.CD007524.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1378\/chest.122.4.1208","article-title":"Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma","volume":"122","author":"Lee-Wong","year":"2002","journal-title":"Chest"},{"issue":"11","key":"10.1002\/14651858.CD007524.pub5-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa1001278","article-title":"Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids","volume":"362","author":"Lemanske","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"1-2","key":"10.1002\/14651858.CD007524.pub5-BIB0033|cit33","first-page":"7","article-title":"A single high dose of inhaled corticosteroids: a possible treatment of asthma exacerbations","volume":"132","author":"Leuppi","year":"2002","journal-title":"Swiss Medical Weekly"},{"issue":"11","key":"10.1002\/14651858.CD007524.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/thx.51.11.1087","article-title":"Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care","volume":"51","author":"Levy","year":"1996","journal-title":"Thorax"},{"issue":"12","key":"10.1002\/14651858.CD007524.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/rmed.2000.0952","article-title":"Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma","volume":"94","author":"Manjra","year":"2000","journal-title":"Respiratory Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007524.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1067\/mai.2001.114709","article-title":"Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations","volume":"107","author":"Matz","year":"2001","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1002\/14651858.CD007524.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/CPM.0000000000000310","article-title":"Can quadrupling inhaled glucocorticoid dose during early asthma exacerbation reduce the need for systemic steroids or hospital admission?","volume":"26","author":"Chung","year":"2019","journal-title":"Clinical Pulmonary Medicine"},{"issue":"12","key":"10.1002\/14651858.CD007524.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"JC65","DOI":"10.7326\/ACPJC-2018-168-12-065","article-title":"Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbations","volume":"168","author":"Maselli","year":"2018","journal-title":"Annals of Internal Medicine"},{"issue":"70","key":"10.1002\/14651858.CD007524.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22700","article-title":"Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST","volume":"22","author":"McKeever","year":"2018","journal-title":"Health Technology Assessment"},{"issue":"Suppl 61","key":"10.1002\/14651858.CD007524.pub5-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"PA1367","DOI":"10.1183\/1393003.congress-2017.PA1367","article-title":"Late breaking abstract - can a self-management plan, which includes a four-fold increase in inhaled corticosteroid dose, reduce severe asthma exacerbations: a randomised, pragmatic trial","volume":"50","author":"McKeever","year":"2017","journal-title":"European Respiratory Journal"},{"issue":"10","key":"10.1002\/14651858.CD007524.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJMoa1714257","article-title":"Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations","volume":"378","author":"McKeever","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"Article number:","DOI":"10.1186\/s13063-016-1608-6","article-title":"FourFold Asthma Study (FAST): a study protocol for a randomised controlled trial evaluating the clinical cost-effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations","volume":"17","author":"Skeggs","year":"2016","journal-title":"Trials"},{"issue":"2","key":"10.1002\/14651858.CD007524.pub5-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2223\/1148","article-title":"Nebulized budesonide to treat acute asthma in children","volume":"80","author":"Milani","year":"2004","journal-title":"Jornal de Pediatria"},{"issue":"8","key":"10.1002\/14651858.CD007524.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3109\/02770909809048967","article-title":"High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack","volume":"35","author":"Nana","year":"1998","journal-title":"Journal of Asthma"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0045|cit45","unstructured":"Patient empowered strategy to reduce asthma morbidity in highly impacted populations; PeRson EmPowered Asthma RElief (PREPARE) clinicaltrials.gov\/ct2\/show\/NCT02995733"},{"issue":"3","key":"10.1002\/14651858.CD007524.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1081-1206(10)63306-6","article-title":"The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children","volume":"86","author":"Nuhoglu","year":"2001","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"17","key":"10.1002\/14651858.CD007524.pub5-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1517\/14656566.2010.526603","article-title":"Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up","volume":"11","author":"O'Connor","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0048|cit48","unstructured":"A study to assess the efficacy and safety of budesonide\/albuterol metered-dose inhaler (BDA MDI\/PT027) in adults and children 4 years of age or older with asthma (MANDALA) clinicaltrials.gov\/ct2\/show\/NCT03769090"},{"issue":"22","key":"10.1002\/14651858.CD007524.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa2203163","article-title":"Albuterol-budesonide fixed-dose combination rescue inhaler for asthma","volume":"386","author":"Papi","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007524.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.pupt.2008.12.013","article-title":"Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma","volume":"22","author":"Pedersen","year":"2009","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD007524.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/jpc.13680","article-title":"Increased doses of inhaled corticosteroids during home management of asthma flare-ups do not reduce the need for systemic steroids","volume":"53","author":"Prentice","year":"2017","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"4","key":"10.1002\/14651858.CD007524.pub5-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1081-1206(10)60601-1","article-title":"Comparison of single 2000-microg dose treatment vs. sequential repeated-dose 500-microg treatments with nebulized budesonide in acute asthma exacerbations","volume":"100","author":"Razi","year":"2008","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD007524.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1164\/ajrccm.157.3.9704022","article-title":"Inhaled flunisolide for acute severe asthma","volume":"157","author":"Rodrigo","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"11","key":"10.1002\/14651858.CD007524.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1164\/rccm.200410-1415OC","article-title":"Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma","volume":"171","author":"Rodrigo","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"10","key":"10.1002\/14651858.CD007524.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM200009073431003","article-title":"A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma","volume":"343","author":"Schuh","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007524.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1542\/peds.2005-2842","article-title":"High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma","volume":"118","author":"Schuh","year":"2006","journal-title":"Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD007524.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1651-2227.2005.tb01806.x","article-title":"The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma","volume":"94","author":"Sekerel","year":"2005","journal-title":"Acta Paediatrica"},{"issue":"5","key":"10.1002\/14651858.CD007524.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1440-1754.1999.355408.x","article-title":"Inhaled budesonide in acute asthma","volume":"35","author":"Singhi","year":"1999","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"8","key":"10.1002\/14651858.CD007524.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1651-2227.1995.tb13786.x","article-title":"Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infections","volume":"84","author":"Svedmyr","year":"1995","journal-title":"Acta Paediatrica"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD007524.pub5-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0091-6749(98)70276-3","article-title":"Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone","volume":"102","author":"Volovitz","year":"1998","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1002\/14651858.CD007524.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.chest.2016.06.026","article-title":"COUNTERPOINT: is escalation of the inhaled corticosteroid dose appropriate for acute loss of asthma control in an attempt to reduce need for oral corticosteroids in children? No","volume":"150","author":"Weinberger","year":"2016","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD007524.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/adc.65.4.407","article-title":"Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home","volume":"65","author":"Wilson","year":"1990","journal-title":"Archives of Disease in Childhood"},{"issue":"6","key":"10.1002\/14651858.CD007524.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2500\/aap.2012.33.3614","article-title":"Early intervention with high-dose inhaled corticosteroids for control of acute asthma exacerbations at home and improved outcomes: a randomized controlled trial","volume":"33","author":"Yousef","year":"2012","journal-title":"Allergy and Asthma Proceedings"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD007524.pub5-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"AB85","DOI":"10.1016\/j.jaci.2010.12.344","article-title":"Ineffectiveness of high-dose inhaled corticosteroids for control of pre-exacerbation asthma symptoms [abstract]","volume":"127","author":"Yousef","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1183\/09031936.93.06060877","article-title":"A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma","volume":"6","author":"Barnes","year":"1993","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD007524.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.anai.2019.12.027","article-title":"Adherence to adding inhaled corticosteroids to rescue therapy in a pragmatic trial with adults with asthma: a pilot study","volume":"124","author":"Cardet","year":"2020","journal-title":"Annals of Allergy, Asthma & Immunology"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0067|cit67","unstructured":"Covidence Veritas Health Innovation"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD007524.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD007524.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1037\/1082-989X.6.2.161","article-title":"Meta-analysis of correlation coefficients: a Monte Carlo comparison of fixed- and random-effects methods","volume":"6","author":"Fields","year":"2001","journal-title":"Psychological Methods"},{"issue":"3","key":"10.1002\/14651858.CD007524.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.jaci.2011.12.983","article-title":"Asthma outcomes: exacerbations","volume":"129","author":"Fuhlbrigge","year":"2012","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD007524.pub5-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1136\/thorax.2003.011858","article-title":"Written action plans for asthma: an evidence-based review of the key components","volume":"59","author":"Gibson","year":"2004","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0073|cit73","unstructured":"Global Strategy for Asthma Management and Prevention 2015 ginasthma.org\/wp-content\/uploads\/2016\/01\/GINA_Report_2015_Aug11-1.pdf"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0074|cit74","unstructured":"Global Strategy for Asthma Management and Prevention ginasthma.org\/wp-content\/uploads\/2021\/05\/GINA-Main-Report-2021-V2-WMS.pdf"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0075|cit75","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2307\/2530643","article-title":"Estimation of a common effect parameter from sparse follow-up data","volume":"41","author":"Greenland","year":"1985","journal-title":"Biometrics"},{"issue":"7414","key":"10.1002\/14651858.CD007524.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/14651858.CD201601","article-title":"A revised tool for assessing risk of bias in randomized trials","volume":"10 Suppl 1","author":"Higgins","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0079|cit79","unstructured":"Higgins JPT Li T Sterne J on behalf of the RoB 2 working group on crossover trials Revised Cochrane risk of bias tool for randomized trials (RoB 2). Additional considerations for crossover trials (preliminary tool version, 18 March 2021) www.riskofbias.info\/welcome\/rob-2-0-tool\/rob-2-for-crossover-trials"},{"issue":"7307","key":"10.1002\/14651858.CD007524.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.323.7307.253","article-title":"Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis","volume":"323","author":"Holt","year":"2001","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007524.pub5-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/cea.12179","article-title":"Frequent exacerbators - a distinct phenotype of severe asthma","volume":"44","author":"Kupczyk","year":"2014","journal-title":"Clinical and Experimental Allergy"},{"issue":"Suppl A","key":"10.1002\/14651858.CD007524.pub5-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"9A","DOI":"10.1155\/2004\/271362","article-title":"Adult Asthma Consensus Guidelines Update 2003","volume":"11","author":"Lemiere","year":"2004","journal-title":"Canadian Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD007524.pub5-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/jrsm.1287","article-title":"Machine learning for identifying randomized controlled trials: an evaluation and practitioner\u2019s guide","volume":"9","author":"Marshall","year":"2018","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0084|cit84","unstructured":"McDonald S Noel-Storr AH Thomas J Harnessing the efficiencies of machine learning and Cochrane Crowd to identify randomised trials for individual Cochrane reviews Global Evidence Summit; 2017 Sep 13-16; Cape Town 2017"},{"issue":"3","key":"10.1002\/14651858.CD007524.pub5-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1164\/ajrccm.158.3.9802069","article-title":"Potential masking effects of salmeterol on airway inflammation in asthma","volume":"158","author":"Mcivor","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0086|cit86","unstructured":"Noel-Storr AH Project Transform team Cochrane Crowd: new ways of working together to produce health evidence Evidence Live 2018; 2018 Jun 18-20; Oxford, UK 2018"},{"issue":"4","key":"10.1002\/14651858.CD007524.pub5-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"1901872","DOI":"10.1183\/13993003.01872-2019","article-title":"Overuse of short-acting \u03b22-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme","volume":"55","author":"Nwaru","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD007524.pub5-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1164\/rccm.201810-1931CI","article-title":"Mechanisms and management of asthma exacerbations","volume":"199","author":"Ramsahai","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007524.pub5-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0090|cit90","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2022"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0091|cit91","unstructured":"Current version of RoB 2 riskofbias.info"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0092|cit92","unstructured":"Sch\u00fcnemann HJ Higgins JPT Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). \u00a0Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"issue":"4","key":"10.1002\/14651858.CD007524.pub5-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jaci.2008.08.003","article-title":"Epidemiology of asthma exacerbations","volume":"122","author":"Sears","year":"2008","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9","key":"10.1002\/14651858.CD007524.pub5-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","article-title":"Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"5","author":"Soriano","year":"2017","journal-title":"Lancet Respiratory Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007524.pub5-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S2213-2600(20)30105-3","article-title":"Prevalence and attributable health burden of chronic respiratory diseases, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"8","author":"Soriano","year":"2020","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2046-4053-3-54","article-title":"Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram","volume":"3","author":"Stovold","year":"2014","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0098|cit98","unstructured":"Flemyng E Kew K DOSE-AST supplementary file data Figshare URL https:\/\/doi.org\/10.6084\/m9.figshare.15797838.v1 2021 10.6084\/m9.figshare.15797838.v1"},{"key":"10.1002\/14651858.CD007524.pub5-BIB0099|cit99","unstructured":"Flemyng E Kew K DOSE-AST RoB2 concensus data file Figshare URL https:\/\/doi.org\/10.6084\/m9.figshare.15752415 2021 10.6084\/m9.figshare.15752415"},{"issue":"17","key":"10.1002\/14651858.CD007524.pub5-BIB0100|cit100","first-page":"30604","article-title":"Living Systematic Review Network. Living Systematic Reviews: 2. Combining Human and Machine Effort","volume":"S0895-4356","author":"Thomas","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD007524.pub5-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"1800703","DOI":"10.1183\/13993003.00703-2018","article-title":"Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature","volume":"52","author":"Volmer","year":"2018","journal-title":"European Respiratory Journal"},{"issue":"CD007524","key":"10.1002\/14651858.CD007524.pub5-BIB0102|cit102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007524.pub4","article-title":"Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children","author":"Kew","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007524.pub5-BIB0103|cit103","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007524","article-title":"Increased versus stable doses of inhaled steroids for exacerbations of chronic asthma in adults and children","author":"Quon","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD007524.pub5-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007524.pub3","article-title":"Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children","author":"Quon","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T21:03:34Z","timestamp":1761253414000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007524.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":104,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007524.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]}}}